Keyphrases
Cisplatin Resistance
100%
Cisplatin
100%
Testicular Germ Cell Tumor
100%
Histone Deacetylase Inhibitor (HDACi)
100%
Panobinostat
100%
Belinostat
100%
NCCIT
75%
Tumor Patients
50%
Cell Viability
25%
Cancer Mortality
25%
Subclone
25%
Patient Samples
25%
Novel Treatments
25%
Treatment Options
25%
Cell Cycle Arrest
25%
Cell Death
25%
Apoptosis
25%
Cancer Causes
25%
Differential Expression
25%
Effective Therapy
25%
Pathobiology
25%
In Silico
25%
Acetylation
25%
Epigenetic Deregulation
25%
Reduced Cell
25%
FDA-approved Drugs
25%
Cleaved caspase-3
25%
Ki-67 Index
25%
Combination Agents
25%
Epidrugs
25%
Medicine and Dentistry
Germinoma
100%
Cisplatin
100%
Histone Deacetylase Inhibitor
100%
Panobinostat
100%
Belinostat
100%
Cell Line
28%
Malignant Neoplasm
14%
Cell Viability
14%
Cell Death
14%
Cell Cycle Arrest
14%
Upregulation
14%
Programmed Cell Death
14%
P21
14%
In Silico
14%
Cell Cycle Checkpoint
14%
Acetylation
14%
Caspase 3
14%
GCT Cell Line
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
100%
Histone Deacetylase Inhibitor
100%
Panobinostat
100%
Germ Cell Tumor
100%
Belinostat
100%
Malignant Neoplasm
14%
Cell Viability
14%
Caspase 3
14%
Neuroscience
Cisplatin
100%
Histone Deacetylase Inhibitor
100%
Panobinostat
100%
Belinostat
100%
Cell Line
42%
Cell Viability
14%
Cell Cycle Checkpoint
14%
Cell Cycle Arrest
14%
Acetylation
14%
Cell Death
14%
Caspase 3
14%